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Objective: To investigate the analgesic and anti-inﬂammatory property and possible
involvement of opioid receptors of ethyl acetate extract from aerial parts of Daphne
mucronata (D. mucronata) in mice by formalin test.
Methods: Single doses of 2.5, 5.0 and 10.0 mg/kg of body weight of ethyl acetate extract
of D. mucronata were intraperitoneally administered to the mice 30 min before analgesic
test. The anti-nociceptive effect of preparations was evaluated based on the formalin in
mice.
Results: The results indicated that the extract (2.5, 5.0 and 10.0 mg/kg) increased the
pain threshold of mice and induced analgesia in both phases of formalin test. Like
morphine sulfate (5.0 mg/kg, i.p.), the extract also showed more effective analgesic effect
on the late phase of formalin test. Pre-treatment of animals with naloxone (5.0 mg/kg i.p.)
did not inhibit the effects of the extract.
Conclusions: Our ﬁndings suggest that D. mucronata contains potential analgesic and
anti-inﬂammatory compounds which support its traditional use. Moreover, it seems that
the analgesic and anti-inﬂammatory effects of the extract is mediated by non-opioid
mechanisms. Further pharmacological studies are required to determine whether the
analgesic mechanisms are actually responsible for such properties.1. Introduction
Daphne mucronata Royle (Thymelaeaceae) (D. mucronata),
popularly known as Kheweshk, is an indigenous plant grown in
Iran [1]. It is traditionally used as a herbal medicine for the
treatment of various diseases such as cancer [2]. The Daphne
genus consists of about 100 species [3,4]. Only a limitednumber of scientiﬁc studies have been conducted on
D. mucronata so far. Primary phytochemical studies have
demonstrated coumarins and diterpenes as the main active
constituents of D. mucronata [5,6]. Derivatives of these
substances have shown analgesic activity in different animal
models of pain [7,8]. Scientiﬁc studies on other species of
Daphne such as Daphne pontica L. and Daphne oleoides [9]
have provided more documents on the analgesic and anti-
inﬂammatory potential of this plant. However, the analgesic
and anti-inﬂammatory properties and also the involvement of
opioid receptors in mediating of these effects have not been
reported.
The present study attempted to evaluate the analgesic and
anti-inﬂammatory effects of ethyl acetate extract of the aerial
parts of D. mucronata on mice using formalin test. The
involvement of opioid receptors in analgesic effects of the
extract was also determined.article under the CC BY-NC-ND license (http://
Figure 1. Time course of the formalin test response after administration of
D. mucronata ethyl acetate extract in mice.
D. mucronata royal extract (2.5, 5.0, 10.0 mg/kg, i.p.) or morphine (5.0 mg/
kg, i.p.) administrated 30 min before formalin 2.5% injection to the mouse
hind paw. The analgesic response in all groups (including morphine treated
group), only compared with control that received saline, intraperitoneally.
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2.1. Plant material
Aerial parts of D. mucronata were collected from Kerman-
shah Region (Kermanshah Province, Iran). This plant species has
been identiﬁed by herbarium of Shahed University, Tehran, Iran.
2.2. Preparation of the ethyl acetate extract
Aerial parts of D. mucronata were washed, chopped, air-
dried under shade and powdered. The powder was stored in an
airtight container. About 100 g of dried powder was soaked in
500 mL of ethyl acetate for 48 h with occasional shaking and
then it was passed through muslin cloth and ﬁltered through the
ﬁlter paper. The extract was ﬁnally dried using a freeze dryer.
First plant extracts were prepared by dissolving the plant extract
in dimethyl sulfoxide. The ﬁnal concentrations of dimethyl
sulfoxide in the injection solution after dilution were less than
0.01% (v/v). In the present study three doses of the extract (2.5,
5.0 and 10.0 mg/kg) were selected based on our preliminary
studies in order to evaluate their analgesic effects.
2.3. Animals
Male mice (20–25 g) were obtained from the animal house of
Tehran University, Tehran, Iran. The animals were kept in a
room with controlled temperature of (22 ± 2) C and a 12 h light/
dark cycle with free access to food and water ad libitum. The
experimental protocol was approved by the Ethics Committee
for Animal Research of the Shahed University of Tehran.
2.4. Formalin test
Formalin test was performed by assessing the formalin-
induced paw licking response in mice. About 20 mL of 1%
formalin, prepared in 0.9% saline, were subcutaneously injected
into the dorsal hind paw of male mice (20–25 g) immediately
placed in transparent box for observation. The extract was
injected at doses of 2.5, 5.0 and 10.0 mg/kg i.p. 30 min before
formalin injection to the mice. The positive control group
received morphine (Daru Pakhsh, Iran) at a dose of 5.0 mg/kg.
The pain intensity was then scored and rated according to the
following numerical scales:
0: Quadrupeds are placed on the ﬂoor and the weight is
evenly distributed.
1: The injected paw lightly touches the ﬂoor or another part
of the animal's body and little or no weight is placed upon it.
2: The injected paw is not in contact with any surface. The
un-injected paw is placed ﬁrmly on the ﬂoor.
3: The injected paw is licked, bitten or shaken.
The mice were observed for 60 min after the injection of
formalin and the time (s) spent in each scale (0, 1, 2 and 3) was
recorded. Rating was averaged over 3 min blocks. Numerical
ratings are calculated through the following formula:
Pain rating = ðT1+ 2T2+ 3T3Þ=180
where T1, T2 and T3 are the time (s) spent in categories 1, 2 and
3, respectively during each 3 min block. The nociceptiveresponse includes two phases; the ﬁrst phase is the neurogenic
pain response which was recorded during the ﬁrst 5 min after
formalin injection. The second phase is the inﬂammatory
response which was recorded 5–60 min after formalin injection.
2.5. Participation of opioid system
To investigate the possible participation of the opioid system
on antinociceptive effect of D. mucronata extract, the mice were
pre-treated (30 min) before receiving the extract (10.0 mg/kg,
i.p.) or morphine (5.0 mg/kg, i.p.) with naloxone (5.0 mg/kg,
i.p.). The nociceptive response was recorded immediately after
the formalin injection.
2.6. Statistical analysis
GraphPadPrism forWindowsversion5wasused for all data and
statistical analysis. All experimental groups consisted of six ani-
mals. The results were expressed as mean ± SEM. The time-course
curves were subjected to Two-way (treatment x time) repeated
measures analysis of variance (ANOVA) followed by Bonferroni
post-hoc test. P < 0.05 was considered statistically signiﬁcant.
3. Results
3.1. Formalin test results
Figure 1 shows the effect of different doses of extract (2.5,
5.0 and 10.0 mg/kg) on the time course of formalin induced
nociception in mice (n = 6), compared to morphine (5.0 mg/kg).
Injection of formalin evoked a retinue biphasic behavior in
nociceptors of the mice (Figure 1). The extract injection
signiﬁcantly reduced the pain behavior of mice in both phases of
formalin test and also induced effective analgesia in mice
(P < 0.01) (Figure 2). The extract showed effective anti-
nociceptive changes at 2.5–10.0 mg/kg in both phases of
formalin test, compared to morphine (5.0 mg/kg).
3.2. Opioid independence analgesic action
Naloxone (5.0 mg/kg, i.p.) did not signiﬁcantly change the
antinociceptive effect of the extract in both phases of the test
(Figure 3A, B). Whereas, morphine-induced analgesia (5.0 mg/kg)
was completely reversed at the presence of naloxone.
Figure 2. Pain score of mice in the early (A) and late (B) phases of
formalin test after administration of different doses of the extract (2.5, 5.0,
and 10.0 mg/kg, i.p.) and morphine (5.0 mg/kg, i.p.).
Each point represents the mean ± SEM, n = 6. The asterisks denote the
signiﬁcance levels compared with the control group (ANOVA). *: P < 0.01;
**: P < 0.001; ***: P < 0.000 1. Morp: Morphine; Nal: Naloxone.
Figure 3. Pretreatment with naloxone showing no signiﬁcant effect on the
most effective analgesic dose (10.0 mg/kg) of the D. mucronata extract in
the early (A) and late (B) phases of formalin test.
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The present study revealed the analgesic effect of
D. mucronata extract on both phases of formalin test. This ﬁnding
indicates that the analgesic effect of the extract mediated both
centrally and peripherally. Naloxone pretreatment revealed that
the pain modulatory effect of extract was opioid-independent in
both phases of formalin test. In support of our ﬁndings, it has been
demonstrated that many species of this plant (Thymelaeaceae)
were being used in the treatment of various kinds of pain for
hundreds of years in Asia [10]. The analgesic and anti-
inﬂammatory property was also found in other Daphne genus [11].Based on previous studies on pharmacological activity of
some species of Daphne genus, it has been shown that they
signiﬁcantly delayed the adjuvant-induced nociceptive response
and eased the paw swelling. In addition, they evidently inhibited
the production of prostaglandin E2 and interleukin-1b and
enhanced the activities of superoxide dismutase and catalase in
the tissue of paws injected with the adjuvant. Furthermore, they
remarkably reduced the content of nitric oxide and inactivated
the activity of nitric oxide synthase in brain tissue of experi-
mental animals [9]. The results of an in vitro study indicated the
inhibitory effect of D. mucronata extract on tumor necrosis
factor alpha receptor [12]. These pain modulatory mechanisms
can be considered as non-opioid analgesic mechanisms [13].
More effective analgesic action of the extract on the late phase
of formalin test indicated that there are other peripheral anti-
inﬂammatory effects. Thus, the anti-inﬂammatory effect of
such coumarins as daphnetin, found in the extract, was
demonstrated [14].
It seems that the extract might act via activation of several
opioid-independent pain controlling systems. Further studies are
needed to identify exact mechanisms responsible for the anti-
nociceptive and anti-inﬂammatory properties of D. mucronata
extract.
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